Protein restriction in CKD: an outdated strategy in the modern era

Area of Science:

• Nephrology
• Nutritional Science
• Pharmacotherapy

Background:

• Traditional chronic kidney disease (CKD) management often involves dietary protein restriction to slow disease progression and delay end-stage renal disease (ESRD).
• Emerging evidence questions the established benefits of protein restriction and highlights potential risks like malnutrition and decreased quality of life.
• This necessitates a re-evaluation of current CKD dietary guidelines.

Purpose of the Study:

• To critically review the rationale and evidence supporting protein restriction in CKD management.
• To analyze the potential risks associated with protein restriction, including malnutrition and reduced quality of life.
• To advocate for a personalized approach to CKD care, integrating nutritional adequacy and pharmacotherapy.

Main Methods:

• Literature review of existing clinical trials and evidence on protein restriction in CKD.
• Critical analysis of the purported benefits versus the documented risks of dietary protein restriction.
• Synthesis of current therapeutic advances for a comprehensive CKD management strategy.

Main Results:

• The efficacy of traditional protein restriction in slowing CKD progression is increasingly debated.
• Malnutrition and impaired quality of life are significant potential adverse effects of protein-restricted diets.
• Novel pharmacotherapies offer promising avenues for optimizing CKD patient outcomes.

Conclusions:

• Protein restriction in CKD requires a more nuanced, individualized approach rather than a blanket recommendation.
• Nutritional adequacy, alongside effective pharmacotherapy, should be central to CKD management strategies.
• Integrating advances like ACE inhibitors, SGLT2 inhibitors, and GLP-1 receptor agonists can improve patient outcomes.